Cargando…

The ever wider clinical spectrum of RMND1-related disorders and limitedness of phenotype-based classifications

ABSTRACT: RMND1 has been identified as a mitochondriopathy-associated gene less than 12 years ago. The most common phenotype related to this gene is an early onset, severe form of encephalomyopathy that leads to death in a medium time of three years after birth. However, milder and later onset prese...

Descripción completa

Detalles Bibliográficos
Autores principales: Rioux, Alexis V., Bergeron, Nicolas AD., Riopel, Julie, Marcoux, Nicolas, Thériault, Catherine, Gould, Peter V., Garneau, Alexandre P., Isenring, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560146/
https://www.ncbi.nlm.nih.gov/pubmed/37584739
http://dx.doi.org/10.1007/s00109-023-02356-x
_version_ 1785117666680242176
author Rioux, Alexis V.
Bergeron, Nicolas AD.
Riopel, Julie
Marcoux, Nicolas
Thériault, Catherine
Gould, Peter V.
Garneau, Alexandre P.
Isenring, Paul
author_facet Rioux, Alexis V.
Bergeron, Nicolas AD.
Riopel, Julie
Marcoux, Nicolas
Thériault, Catherine
Gould, Peter V.
Garneau, Alexandre P.
Isenring, Paul
author_sort Rioux, Alexis V.
collection PubMed
description ABSTRACT: RMND1 has been identified as a mitochondriopathy-associated gene less than 12 years ago. The most common phenotype related to this gene is an early onset, severe form of encephalomyopathy that leads to death in a medium time of three years after birth. However, milder and later onset presentations have been reported in some individuals, including two in whom the mitochondriopathy was identified at ~ 40 years of age, and the early onset presentations have been the object of no reports in those who survived beyond age 10. It is thus unclear how lethal RMND1-related conditions really are. We herein describe the oldest case to have been identified hitherto with this condition, i.e., that of a white female who was 61 at the time of diagnosis but was still active in her everyday life. The gene defect identified was nonetheless associated with many manifestations including ovarian insufficiency and sensorineural hearing loss (two features of what is currently designated as Perrault syndrome) as well as chronic renal failure, asymptomatic myopathy, leukopenia, and a few others. In our opinion, this case is of great translational interest for at least three reasons. First, it hints towards the possibility of near-normal life expectancies in some if not many individuals with RMND1 insufficiency. Second, it underlines the wide clinical spectrum associated with this gene. Third, it brings us to question the use of eponyms and syndromic features to identify the true etiology of multisystemic phenotypes. KEY MESSAGES: RMND1-related conditions typically manifest at an early age with a progressive and lethal form of encephalomyopathy. More benign presentations have been described with some being categorized as Perrault syndrome but none have been diagnosed after the age of 45. The clinical spectrum and presenting age of RMND1-related mitochondriopathies are probably much more varied than implied in the current literature. . The case reported in this manuscript illustrates the limitedness of phenotype-based classifications of genetic disorders to identify the defect at cause.
format Online
Article
Text
id pubmed-10560146
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-105601462023-10-09 The ever wider clinical spectrum of RMND1-related disorders and limitedness of phenotype-based classifications Rioux, Alexis V. Bergeron, Nicolas AD. Riopel, Julie Marcoux, Nicolas Thériault, Catherine Gould, Peter V. Garneau, Alexandre P. Isenring, Paul J Mol Med (Berl) Original Article ABSTRACT: RMND1 has been identified as a mitochondriopathy-associated gene less than 12 years ago. The most common phenotype related to this gene is an early onset, severe form of encephalomyopathy that leads to death in a medium time of three years after birth. However, milder and later onset presentations have been reported in some individuals, including two in whom the mitochondriopathy was identified at ~ 40 years of age, and the early onset presentations have been the object of no reports in those who survived beyond age 10. It is thus unclear how lethal RMND1-related conditions really are. We herein describe the oldest case to have been identified hitherto with this condition, i.e., that of a white female who was 61 at the time of diagnosis but was still active in her everyday life. The gene defect identified was nonetheless associated with many manifestations including ovarian insufficiency and sensorineural hearing loss (two features of what is currently designated as Perrault syndrome) as well as chronic renal failure, asymptomatic myopathy, leukopenia, and a few others. In our opinion, this case is of great translational interest for at least three reasons. First, it hints towards the possibility of near-normal life expectancies in some if not many individuals with RMND1 insufficiency. Second, it underlines the wide clinical spectrum associated with this gene. Third, it brings us to question the use of eponyms and syndromic features to identify the true etiology of multisystemic phenotypes. KEY MESSAGES: RMND1-related conditions typically manifest at an early age with a progressive and lethal form of encephalomyopathy. More benign presentations have been described with some being categorized as Perrault syndrome but none have been diagnosed after the age of 45. The clinical spectrum and presenting age of RMND1-related mitochondriopathies are probably much more varied than implied in the current literature. . The case reported in this manuscript illustrates the limitedness of phenotype-based classifications of genetic disorders to identify the defect at cause. Springer Berlin Heidelberg 2023-08-16 2023 /pmc/articles/PMC10560146/ /pubmed/37584739 http://dx.doi.org/10.1007/s00109-023-02356-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Rioux, Alexis V.
Bergeron, Nicolas AD.
Riopel, Julie
Marcoux, Nicolas
Thériault, Catherine
Gould, Peter V.
Garneau, Alexandre P.
Isenring, Paul
The ever wider clinical spectrum of RMND1-related disorders and limitedness of phenotype-based classifications
title The ever wider clinical spectrum of RMND1-related disorders and limitedness of phenotype-based classifications
title_full The ever wider clinical spectrum of RMND1-related disorders and limitedness of phenotype-based classifications
title_fullStr The ever wider clinical spectrum of RMND1-related disorders and limitedness of phenotype-based classifications
title_full_unstemmed The ever wider clinical spectrum of RMND1-related disorders and limitedness of phenotype-based classifications
title_short The ever wider clinical spectrum of RMND1-related disorders and limitedness of phenotype-based classifications
title_sort ever wider clinical spectrum of rmnd1-related disorders and limitedness of phenotype-based classifications
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560146/
https://www.ncbi.nlm.nih.gov/pubmed/37584739
http://dx.doi.org/10.1007/s00109-023-02356-x
work_keys_str_mv AT riouxalexisv theeverwiderclinicalspectrumofrmnd1relateddisordersandlimitednessofphenotypebasedclassifications
AT bergeronnicolasad theeverwiderclinicalspectrumofrmnd1relateddisordersandlimitednessofphenotypebasedclassifications
AT riopeljulie theeverwiderclinicalspectrumofrmnd1relateddisordersandlimitednessofphenotypebasedclassifications
AT marcouxnicolas theeverwiderclinicalspectrumofrmnd1relateddisordersandlimitednessofphenotypebasedclassifications
AT theriaultcatherine theeverwiderclinicalspectrumofrmnd1relateddisordersandlimitednessofphenotypebasedclassifications
AT gouldpeterv theeverwiderclinicalspectrumofrmnd1relateddisordersandlimitednessofphenotypebasedclassifications
AT garneaualexandrep theeverwiderclinicalspectrumofrmnd1relateddisordersandlimitednessofphenotypebasedclassifications
AT isenringpaul theeverwiderclinicalspectrumofrmnd1relateddisordersandlimitednessofphenotypebasedclassifications
AT riouxalexisv everwiderclinicalspectrumofrmnd1relateddisordersandlimitednessofphenotypebasedclassifications
AT bergeronnicolasad everwiderclinicalspectrumofrmnd1relateddisordersandlimitednessofphenotypebasedclassifications
AT riopeljulie everwiderclinicalspectrumofrmnd1relateddisordersandlimitednessofphenotypebasedclassifications
AT marcouxnicolas everwiderclinicalspectrumofrmnd1relateddisordersandlimitednessofphenotypebasedclassifications
AT theriaultcatherine everwiderclinicalspectrumofrmnd1relateddisordersandlimitednessofphenotypebasedclassifications
AT gouldpeterv everwiderclinicalspectrumofrmnd1relateddisordersandlimitednessofphenotypebasedclassifications
AT garneaualexandrep everwiderclinicalspectrumofrmnd1relateddisordersandlimitednessofphenotypebasedclassifications
AT isenringpaul everwiderclinicalspectrumofrmnd1relateddisordersandlimitednessofphenotypebasedclassifications